Globe Life (NYSE:GL) Issues Quarterly Earnings Results

Key Points

• Globe Life reported a quarterly earnings of $4.81 EPS, exceeding analysts' expectations of $4.52 by $0.29.
• The company declared a quarterly dividend of $0.27, with a dividend yield of 0.8%, to be paid on October 31st to stockholders of record on October 3rd.
• Following the earnings report, GL stock decreased by 0.4%, trading at $135.52 with a market cap of $10.98 billion.

Globe Life (NYSE:GL - Get Free Report) released its earnings results on Wednesday. The company reported $4.81 earnings per share for the quarter, topping the consensus estimate of $4.54 by $0.27, Zacks reports. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.During the same quarter in the previous year, the firm earned $3.44 earnings per share. Globe Life updated its FY 2026 guidance to 14.600-15.300 EPS and its FY 2025 guidance to 14.400-14.600 EPS.

Globe Life Stock Performance

Shares of Globe Life stock traded down $0.49 during mid-day trading on Wednesday, hitting $135.52. 681,848 shares of the stock were exchanged, compared to its average volume of 631,337. Globe Life has a 12 month low of $100.27 and a 12 month high of $147.83. The company has a 50-day simple moving average of $139.70 and a 200 day simple moving average of $129.13. The company has a market capitalization of $10.98 billion, a P/E ratio of 10.83 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be paid a $0.27 dividend. The ex-dividend date is Friday, October 3rd. This represents a $1.08 annualized dividend and a yield of 0.8%. Globe Life's dividend payout ratio (DPR) is 8.63%.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total value of $1,767,250.00. Following the transaction, the chief executive officer owned 32,747 shares of the company's stock, valued at approximately $4,629,770.86. The trade was a 27.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO James Matthew Darden sold 33,270 shares of Globe Life stock in a transaction on Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the sale, the chief executive officer owned 49,842 shares in the company, valued at $6,758,076.78. The trade was a 40.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 84,722 shares of company stock valued at $11,733,793. Insiders own 1.51% of the company's stock.

Hedge Funds Weigh In On Globe Life

A number of hedge funds and other institutional investors have recently made changes to their positions in GL. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life during the 2nd quarter worth approximately $28,000. MUFG Securities EMEA plc purchased a new stake in Globe Life in the second quarter worth about $31,000. Headlands Technologies LLC lifted its stake in shares of Globe Life by 893.6% during the 2nd quarter. Headlands Technologies LLC now owns 775 shares of the company's stock valued at $96,000 after buying an additional 697 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Globe Life during the second quarter worth $228,000. Finally, WINTON GROUP Ltd purchased a new position in shares of Globe Life in the second quarter valued at $308,000. Institutional investors own 81.61% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on GL. BMO Capital Markets reaffirmed a "market perform" rating and issued a $149.00 price objective (up from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. JPMorgan Chase & Co. increased their price target on Globe Life from $145.00 to $160.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Cfra Research raised Globe Life to a "moderate buy" rating in a research note on Friday, July 25th. Keefe, Bruyette & Woods upped their price objective on shares of Globe Life from $145.00 to $155.00 and gave the company an "outperform" rating in a report on Monday, July 28th. Finally, Morgan Stanley set a $179.00 price objective on shares of Globe Life and gave the stock an "overweight" rating in a research report on Tuesday, October 7th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $152.11.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.